Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Perfusion. 2024 Jan;39(1):60-65. doi: 10.1177/02676591211047774. Epub 2021 Sep 23.
Extracorporeal Membrane Oxygenation (ECMO) is commonly associated with a high blood transfusion requirement. Jehovah's Witness patients present a particular challenge. The impossibility of transfusing blood cells and starting anticoagulation treatment are common contraindications for this supportive measure. Here we report the case of a Jehovah's Witness patient with refractory hypoxemia due to influenza A H1N1 pneumonia who required venovenous ECMO for 11 days. We describe the use of a bloodless approach to reduce the waste of blood, avoiding anticoagulation, and improving red blood cell production. We then summarize the current literature on the use of ECMO in Jehovah's Witness patients and, finally, we propose some recommendations for their management.
体外膜肺氧合(ECMO)通常与高输血需求相关。耶和华见证会患者带来了特殊的挑战。不能输注血细胞和开始抗凝治疗是这种支持措施的常见禁忌证。在此,我们报告了一例因甲型 H1N1 流感肺炎导致难治性低氧血症而需要静脉-静脉 ECMO 治疗 11 天的耶和华见证会患者。我们描述了使用无血方法来减少血液浪费,避免抗凝,并改善红细胞生成。然后,我们总结了目前关于 ECMO 在耶和华见证会患者中的应用的文献,最后,我们提出了一些关于他们管理的建议。